Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing

Innovation Proves the Product Works
Dymeka Harrison, a commercialization veteran, argues that breakthrough products alone don’t guarantee lasting companies; adoption hinges on disciplined commercial execution. She cites the 70‑90% startup failure rate as largely driven by underdeveloped commercial foundations. Harrison outlines a holistic commercial system—segmentation, pricing, distribution, partnerships, and operational readiness—as essential for scaling. Ultimately, leaders must align product, finance, operations, and go‑to‑market strategies before seeking growth capital.

Exercise Raises Plaque Yet Cuts Heart Risk
Regular exercise reduces the likelihood of plaque accumulation in the arteries However, many long-term exercisers appear to have coronary artery calcification, indicating atherosclerosis progression The fascinating thing is that despite the higher plaque, those people still have lower rates of cardiovascular disease...

Novo Reports More Triple-G Data From China; Grifols Plots IPO for Biopharma Unit
Novo Nordisk announced that its triple‑agonist candidate UBT251 achieved a mean HbA1c reduction of up to 2.16% after 24 weeks in a phase‑2 study of Chinese patients with type‑2 diabetes. The trial, involving roughly 200 participants, underscores the drug’s potential...
Walsh-Turner JV Finishes $1.5B Ohio State University Hospital
Chicago‑based Walsh Construction and New York‑based Turner Construction have completed a new 26‑story, 1.9‑million‑square‑foot hospital for Ohio State University at a construction cost of $1.5 billion. The Wexner Medical Center University Hospital tower houses 820 beds, 24 operating rooms, extensive NICU,...

Alzheimer’s Disease Data Initiative Doubles $1M Prize Competition for Agentic AI Solutions
The Alzheimer’s Disease Data Initiative announced that Biomni-AD and Prima Mente each won the $1 million Alzheimer’s Insights AI Prize, doubling the competition’s total payout to $2 million. The competition, launched in August 2025 and backed by Bill Gates and a broad...

STAT+: Sarepta Therapeutics Shares Rise on Early Promise for Rare Disease Drugs
Sarepta Therapeutics reported that early‑stage trials of two experimental drugs, SRP‑1001 and SRP‑1003, demonstrated safety and signs of efficacy for rare muscle‑wasting disorders. The data sparked a more than 20% surge in the company’s stock during early trading. The results...

Legacy Systems Present Modern Challenges at the VA
Veterans Affairs is phasing out its decades‑old custom electronic health record (EHR) in favor of a modern, interoperable platform, CMIO Dr. Jonathan Nebeker announced. The new system will support standardized data exchange and enable integration of emerging digital tools such...

Xaira’s First Virtual Cell Model Is Largest To-Date, Toward Complex Biology
Xaira Therapeutics unveiled X-Cell, a 4.9‑billion‑parameter virtual cell model that predicts transcriptome‑level responses to genetic perturbations. The model leverages the company’s 25.6 million‑cell X‑Atlas/Pisces CRISPRi Perturb‑seq dataset and demonstrates zero‑shot performance on unseen T‑cell and iPSC contexts. X-Cell uses a diffusion...

Medilink to Celebrate 30-Year Milestone with Spectacular Awards Evening
Medilink North of England is celebrating its 30th anniversary with a high‑profile awards evening at Sheffield’s Cutlers’ Hall on 30 April. The ceremony will recognize excellence across ten categories, from innovation and digital health to export achievement, sustainability and partnership with...

The Strange Case of the Disappearing ‘Standards of Care’
A New York court awarded Fox Varian $2 million in a landmark detransition malpractice lawsuit, marking the first successful U.S. case of its kind. The verdict held both her therapist and plastic surgeon jointly liable for a double mastectomy performed when...

Asclepius MedTech Limited Named Winner of Big Ideas Challenge
Leeds‑based Asclepius MedTech Limited won the Mayor’s Big Ideas Challenge, receiving £100,000 (≈ $127,000) to scale its Surgfit remote monitoring system. Surgfit uses a disposable wearable sensor to replace hospital visits for pre‑ and post‑operative assessments, aiming to reduce missed risk...

New Treatments Target Faulty Genetic Heart Signals
A new DNA‑methylation (episignature) test can differentiate harmful from benign NOTCH1 variants in congenital heart disease, giving families definitive genetic answers. The assay scans over 740,000 genomic sites to identify a characteristic methylation pattern linked to disease‑causing mutations. Positive results...

What Two ER Visits Taught Me About American Healthcare Leadership Failures
The CEO of Sollis Health recounts two COVID‑19 ER visits that revealed how fragmented American healthcare forces patients to coordinate their own care. Despite shared electronic medical records, hospitals rejected each other's data, leading to hours of waiting and unnecessary...

A New Opportunity to Reduce Resident Burnout: Young Doctors Are AI Natives
Resident physicians are experiencing burnout at rates higher than any other U.S. worker, driven by demanding schedules, financial pressures, and limited control over time. Traditional mental‑health services often fail to accommodate their irregular hours, prompting many to turn to AI‑based...

Key Amenity Categories in Luxury Rehabs, According to The Sanctuary at Sedona
The Sanctuary at Sedona outlines a comprehensive luxury rehab checklist that blends high‑end amenities with rigorous clinical care. It highlights seven amenity categories—privacy, clinical depth, personalization, integrative wellness, advanced tech, environment, and hospitality—each designed to improve retention and therapeutic engagement....

Why Gaps in Vaccine Coverage Leave Canadian Employers Exposed
Canadian employers are leaving significant gaps in adult vaccine coverage, with only about 60% of private benefit plans offering any vaccination benefits. Even when coverage exists, reimbursement levels and communication are inconsistent, leading to low uptake among working‑age adults. The...
British Psychological Society Backs Inquiry's Call for Expanded NHS Mental‑health Support
The British Psychological Society (BPS) has publicly welcomed the Covid inquiry’s recommendation to broaden psychological support for NHS workers, pledging to help shape the new Staff Treatment Hubs in the NHS 10‑Year Plan. The move underscores growing pressure to address...
Countries Ban Teen Social Media, Raising New Parenting Challenges
France, Spain, Malaysia and Australia have announced bans on social‑media use for minors, and the United Kingdom is weighing a similar measure. Lawmakers say the steps protect mental health and give parents a clear rule, but experts warn the bans...
Study Finds New Dads Face 30% Higher Risk of Depression by Year One
Researchers analyzing 1.9 million births in Sweden discovered that new fathers experience a 30% increase in depression and stress disorders by the end of their child’s first year. The findings, published in JAMA Network Open, underscore a long‑overlooked mental‑health gap for...

PCPs Must Prioritize Heart Health in Perimenopause
Stairwell Chronicles - A letter to Primary Care Physicians about their perimenopausal patients. #wellnesswednesday #pcp #midlife #hearthealth #stairwellchronicles
Jogye Order Launches AI‑Era Seon Meditation Summit in Seoul on April 3
The Jogye Order of Korean Buddhism announced the 2026 International Seon Meditation Summit and Seon Meditation Festival, set to open on April 3 at Seoul’s Bong‑eun Cultural Center. The three‑day event will showcase AI‑driven meditation tools, a “mind‑prescription” program, and a...

N.J. EMS Adds Long-Acting Buprenorphine to Prehospital Overdose Care
Cooper EMS in New Jersey has added extended‑release injectable buprenorphine to its prehospital protocols, allowing paramedics to administer a week‑to‑month‑long opioid‑use‑disorder medication after reversing an overdose. The agency previously used sublingual buprenorphine on its Mobile Intensive Care Unit, but the...
Medicus Report Flags 5,350 Hospitalist Shortfall, Opening Door for Consulting Firms
Medicus Healthcare Solutions released a 2026 report showing a projected shortfall of 5,350 hospitalists nationwide and a 69‑day average time to fill openings. The data highlights a growing supply‑demand imbalance that consulting firms can leverage to advise health systems on...
Merck & Co. Nears $6 Billion All‑Cash Deal for Terns Pharma, Boosting Oncology Portfolio
Merck & Co. is in advanced negotiations to acquire U.S. biotech Terns Pharma for an all‑cash price of about $6 billion. The news lifted Merck shares 0.5% to $116.99 and sent Terns stock soaring 12% to $55.97, underscoring the deal’s market...

Microneedle Vaccine Patch Company Raises $50M for Pivot to GLP-1 Delivery
Terrestrial Bio, the microneedle vaccine patch pioneer originally founded as Vaxess Technologies, announced a $50 million Series B financing round to shift its focus from vaccines to GLP‑1 peptide delivery. The capital, led by a consortium of biotech investors, will fund clinical...
FDA Halts Elevidys Trial, Fueling New Right‑to‑Try Debate for Duchenne Families
A mother’s plea after the FDA halted the Elevidys gene‑therapy trial for her son with Duchenne muscular dystrophy has reignited criticism of the 2018 Right‑to‑Try Act. The agency’s decision, triggered by two deaths in a broader trial, cuts off a...

AI-Powered Virtual Oncology Gets Smarter: Reimagine Care Advances Remi to Capture the Nuance of Cancer Patient Conversations
Reimagine Care announced a major upgrade to its AI‑powered virtual oncology assistant, Remi, shifting from rule‑based scripts to natural‑language understanding that can interpret complex patient messages. The SMS‑based platform now adds safety guardrails, AI‑assisted clinician summaries, and expanded monitoring for...

Young People Less Satisfied with the NHS - Survey
The 2025 British Social Attitudes survey shows only one‑in‑five people under 35 are satisfied with the NHS, compared with more than a third of those over 65. Overall satisfaction rose to 26%, the first increase since before the Covid pandemic,...
Affordable €2000 Robot Offers Elderly Care and Home Automation
This robot was designed for elderly care. It can have conversations with the user, measure blood pressure and heart rate, operate the smart elements of the house from heat to lights and do simpler tasks. It's quite the accomplishment (or claims) for...

Kidney Disease Hijacks Gut Microbiome, Accelerating Decline
As a medical school professor, this is one of the most terrifying feedback loops I've seen in medicine. UC Davis researchers just published in Science showing how chronic kidney disease hijacks gut bacteria to destroy your kidneys FASTER. The mechanism: 1. Damaged kidneys...

GrayMatters Health Announces Appointment of Five Expert Advisors
GrayMatters Health announced the appointment of five expert advisors to accelerate the commercial growth of Prism, its digital brain‑biomarker platform for PTSD and depression. The advisors—former Congressman Patrick J. Kennedy and psychiatrists Owen Scott Muir, Linda Carpenter, Kenneth Pages, and...

Study Shows How Lymph Node Architecture Affects Cancer Growth
Researchers from EMBL Heidelberg and partner institutions have created the first detailed map of immune and stromal cell organization within human lymph nodes, revealing how this architecture deteriorates in lymphomas. They discovered an inflammatory vicious cycle where T‑cell interferon signals...

The First Dose Is Everything: Enhancing Adherence and Persistence with Noble SureStartRx™
Noble’s SureStartRx™ program ships remote demonstration kits to patients before their first self‑injectable dose, allowing them to practice and build confidence. The initiative accelerates therapy initiation, improves short‑term adherence, and extends treatment persistence. Director Sean Glynn highlights how this early...

The ‘Disinformation Dozen’: Targeted by Government, Maligned by Media. Where Are They Today?
Six years after the Center for Countering Digital Hate (CCDH) released its “Disinformation Dozen” list, the targeted anti‑vaccine figures recount extensive deplatforming, revenue loss, and personal harassment. The Biden administration’s pressure on major platforms amplified the censorship, while the list’s...

Vitamin D Guidelines Miscalculated; Sunlight, Not Pills, Solves Deficiency
The Vitamin D Lie Your Doctor May Still Believe The official recommendation was based on a mathematical mistake. The "normal" level on your lab report may be dangerously low. And the best fix isn't a pill — it's free https://x.com/robertlufkinmd/status/2036754584954167391

Regeneron and Sanofi Report MHLW’s Approval of Dupixent to Treat Bullous Pemphigoid
Japan’s Ministry of Health, Labour and Welfare approved Dupixent (dupilumab) for adults with moderate-to-severe bullous pemphigoid, marking the first targeted therapy for the disease in the country. The approval is based on the phase II/III ADEPT trial, which enrolled 106...

Why IVF Fails: Top Reasons & How to Improve Your Success
A failed IVF cycle is most often traced to embryonic chromosomal abnormalities, not the transfer itself, with implantation rates dropping from about 43% for women under 35 to roughly 9% for those over 41. The article outlines seven primary failure...

Maze Meets Own Expectations in Phase 2 Kidney Disease Trial in the Same Arena as Vertex
Maze Therapeutics reported that its Phase 2 trial of the genetic kidney disease candidate MZ‑001 achieved its primary efficacy and safety goals, showing a roughly 30% slowdown in eGFR decline versus placebo. The double‑blind study enrolled 150 patients with autosomal dominant...

Ignored DNR Hospital Policy: A Family’s Tragic End-of-Life Story
A 74‑year‑old Texas woman with a documented Do‑Not‑Resuscitate (DNR) order was rushed to the ER, where staff performed CPR and intubated her despite verbal confirmation of her wishes. Hospital policy required a physical DNR form filed by registration, which the...

Ultra-Processed Foods Linked to Behavioral Issues in Pre-Schoolers
A University of Toronto study published in JAMA Network Open found that preschoolers who consume high levels of ultra‑processed foods at age three are more likely to exhibit anxiety, aggression, hyperactivity and fearfulness by age five. The analysis of over...

Hospital Waited Two Days Before Raising Alarm About Meningitis Outbreak
The East Kent Hospitals NHS Trust delayed reporting a suspected meningitis case at Queen Elizabeth the Queen Mother Hospital by two days, breaching the Health Protection Regulations that require immediate notification. The lag slowed contact tracing and public warnings, contributing...
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
WuXi Biologics reported record 2025 results, with revenue up 16.7% and IFRS gross profit climbing 30.9%, lifting its gross margin to 46%. The growth was driven by expanding research, development and manufacturing contracts and tighter cost control across its global...

Actionable Monitoring Beats Data Overload in Cardiac Care
Health care has become better at saving people once they are already in trouble. That does not mean we have become good at catching trouble early. This episode of The Podcast by KevinMD gets at a hard truth in cardiac care: we...
ACA's Bans and Tax Rules Kill Portable Individual Plans
And, the ACA banned individual guaranteed renewable plans which existed, and protected against the emergence of preexisting conditions. The tax deduction for employer based group plans, but not for contributions to portable individual plans nails the coffin. Great essay.
Adolescents Are the Missing Middle Falling Through the Cracks of TB Care
Adolescents represent a hidden segment of the tuberculosis epidemic, with roughly 750,000 teens contracting TB worldwide each year and about 20,000 cases in South Africa alone. Because health data split patients into children or adults, teenagers fall between categories, leading...
Higher Phenotypic Age Accelerates Cancer Survivors' Mortality Risk
The association between phenotypic age acceleration and the risk of all-cause and cancer mortality among cancer survivors: NHANES 1999–2018 "Our findings reveal a significant linear correlation between PhenoAgeAccel and both all-cause and cancer-specific mortality in cancer survivors." https://t.co/Rt7v8ECOB6
MRK Likely to Rerun TERN Study for Data
Based on previous form $MRK will probably now rerun the $TERN study, just to prove to itself that the data were real.
Analysts Bullish on MAZE, yet Pre‑market Price Drops
$MAZE - Analysts pitching tent poles over the AMKD data, yet stock is down pre market. What's the disconnect?
Merck Spends $6.7B on CML Drug Despite Gleevec Era
It's amazing that 25 years after Gleevec we are still watching drug companies pay billions for new drugs for CML. And that, in Adam's previous story, a once deadly cancer was referred to as a chronic disease. Anyway, $MRK buys $TERN...
AVXL Withdraws Alzheimer's Drug From EMA After Rejection
$AVXL pulled its blarcamesine Alzheimer's application from the EMA after regulators there said there was no fking way it was going to approve a drug that does not work.